Featured

‘These are not the type of fund-like investments where the expectations of the acquiring fund’s shareholders would be frustrated,’ the SEC says in new regulatory guidance.

The service provider’s latest acquisition strives to break down barriers between the front and back office.

The states prove to be a battlefield for private equity’s future in healthcare, as antitrust and corporate-practice-of-medicine bills spread.

Given GPs’ increasing reliance on technology for every facet of their work, CFOs need effective relationships with their CTOs to make the most of today’s cutting-edge tools.

There is an often-overlooked $17trn market where the mid-market and smaller managers can compete within their own weight class for retirement capital, writes Eric Satz, founder and CEO of self-directed IRA platform Alto.

The instruments bear similarities to both NAV loans and dividend recapitalizations.

Some large GPs are hiring chief risk officers, but all firms might benefit from adopting the perspective of professionals like Catherine Addona-Peña of NASDAQ.

Here are responses from industry thought leaders including Goldman Sachs, Carlyle, Apollo and NYCRS across areas such as dealmaking, fundraising and secondaries.

In this podcast, PEI Group editors discuss what GPs say they're focusing on amid the trade war-induced uncertainty, how the secondaries market stands to benefit, and how investors are reacting to the volatile environment.

President Donald Trump’s tariff show is leaving the private equity industry with no choice but to factor the administration’s isolationist tendencies into their models.